Tracking of green fluorescent protein labeled Escherichia coli confirms bacterial translocation in blind loop rat
- PMID: 17720193
- DOI: 10.1016/j.jss.2006.03.030
Tracking of green fluorescent protein labeled Escherichia coli confirms bacterial translocation in blind loop rat
Abstract
Background: Previous investigators have documented small intestinal mucosal injury in blind loop rats. However, the definitive evidence of intestinal bacterial translocation in blind loop animals has been lacking. The purpose of this study was to confirm bacterial translocation in blind loop rats and to evaluate the preventive effect of glutamine on bacterial translocation caused by blind loops.
Materials and methods: Escherichia coli TG1 labeled with green fluorescent protein was used to track bacterial translocation by gavage to rats. Six groups (n = 10) of rats were studied: unoperated control rats; rats with self-emptying blind loop; rats with self-filling blind loop; unoperated control rats treated with glutamine, 400 mg/d; rats with self-emptying blind loop treated with glutamine, 400 mg/d; rats with self-filling blind loop treated with glutamine, 400 mg/d. Representative tissue specimens of the mesenteric lymph nodes, liver, spleen, and kidney were aseptically harvested for bacteria culture.
Results: Bacteria were detected in extraintestinal organs of rats with self-emptying blind loop, self-filling blind loop, and self-filling blind loop treated with glutamine. By fluorescence microscope and XbaI restriction digestion analysis, we elucidated that the bacteria isolated from extraintestinal organs were the same bacteria we gavaged to the rats.
Conclusion: We confirmed bacterial translocation in self-filling blind loop and self-emptying blind loop rats. In addition, we also showed that glutamine prevents bacterial translocation in self-emptying blind loop rats.
Similar articles
-
Green fluorescent protein labeling Escherichia coli TG1 confirms intestinal bacterial translocation in a rat model of chemotherapy.Curr Microbiol. 2006 Jan;52(1):69-73. doi: 10.1007/s00284-005-0177-9. Epub 2005 Dec 26. Curr Microbiol. 2006. PMID: 16392000
-
Pathogenesis of mucosal injury in the blind loop syndrome. Brush border enzyme activity and glycoprotein degradation.J Clin Invest. 1977 Dec;60(6):1321-30. doi: 10.1172/JCI108891. J Clin Invest. 1977. PMID: 410830 Free PMC article.
-
Confirmation and prevention of intestinal barrier dysfunction and bacterial translocation caused by methotrexate.Dig Dis Sci. 2006 Sep;51(9):1549-56. doi: 10.1007/s10620-005-9058-0. Epub 2006 Aug 22. Dig Dis Sci. 2006. PMID: 16927144
-
Small intestinal bacterial overgrowth.Scand J Gastroenterol. 2008;43(9):1030-7. doi: 10.1080/00365520801947074. Scand J Gastroenterol. 2008. PMID: 18609165 Review.
-
[Bacterial overgrowth syndrome].Z Gastroenterol. 2007 Jul;45(7):620-8. doi: 10.1055/s-2007-963045. Z Gastroenterol. 2007. PMID: 17620228 Review. German.
Cited by
-
Animal models to study acute and chronic intestinal inflammation in mammals.Gut Pathog. 2015 Nov 10;7:29. doi: 10.1186/s13099-015-0076-y. eCollection 2015. Gut Pathog. 2015. PMID: 26561503 Free PMC article. Review.
-
Gut Microbiota Imbalance Can Be Associated with Non-malabsorptive Small Bowel Shortening Regardless of Blind Loop.Obes Surg. 2019 Feb;29(2):369-375. doi: 10.1007/s11695-018-3540-1. Obes Surg. 2019. PMID: 30293133
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources